MedCap AB (publ)
Research MedCap AB (publ) (MCAP) on Bullrun: valuation model: 4.5% overvalued, market cap SEK 7.72B, P/E 34.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMCAP
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Valuation signal4.5% overvalued
- Market capSEK 7.72B
- P/E34.3
- Financial periodQ4 2025
- RevenueSEK 591.00M
- Net incomeSEK 64.60M
- Free cash flowSEK 127.70M
- Gross margin59.3%
Valuation Snapshot
Bullrun's latest valuation model marks MedCap AB (publ) as 4.5% overvalued; latest market cap is SEK 7.72B; P/E is 34.3.
About MedCap AB (publ)
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products;
Frequently asked questions
Is MedCap AB (publ) overvalued or undervalued?
Bullrun's valuation model currently marks MedCap AB (publ) as 4.5% overvalued.
What is MedCap AB (publ)'s market cap?
MedCap AB (publ)'s market capitalization is SEK 7.72B.
What is MedCap AB (publ)'s P/E ratio?
MedCap AB (publ)'s price-to-earnings (P/E) ratio is 34.3.
What does MedCap AB (publ) do?
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals;